UBS AM
MJN

UBS AM’s Mead Johnson Nutrition Company MJN Stock Holding History

UBS AM’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-464,548
Closed -$41.4M – 2567
2017
Q1 		$41.4M Buy
464,548
+38,905
+9% +$3.2M 0.04% 464
2016
Q4 		$30.1M Sell
425,643
-10,462
-2% -$780K 0.03% 535
2016
Q3 		$34.5M Sell
436,105
-7,708
-2% -$657K 0.04% 489
2016
Q2 		$40.3M Sell
443,813
-241,119
-35% -$20.4M 0.05% 420
2016
Q1 		$58.2M Buy
684,932
+190,967
+39% +$14.2M 0.07% 316
2015
Q4 		$39M Sell
493,965
-98,811
-17% -$7.78M 0.04% 443
2015
Q3 		$41.7M Sell
592,776
-65,042
-10% -$5.35M 0.05% 427
2015
Q2 		$59.3M Buy
657,818
+33,217
+5% +$3.2M 0.06% 361
2015
Q1 		$62.8M Sell
624,601
-38,356
-6% -$3.87M 0.06% 354
2014
Q4 		$66.7M Buy
662,957
+267
+0% +$26.6K 0.06% 327
2014
Q3 		$63.8M Buy
662,690
+10,221
+2% +$968K 0.06% 327
2014
Q2 		$60.8M Buy
652,469
+12,244
+2% +$1.07M 0.06% 333
2014
Q1 		$53.2M Buy
640,225
+44,031
+7% +$3.57M 0.06% 356
2013
Q4 		$49.9M Buy
596,194
+30,433
+5% +$2.48M 0.06% 349
2013
Q3 		$42M Sell
565,761
-48
-0% -$3.6K 0.05% 368
2013
Q2 		$44.8M Buy
+565,809
New +$45.4M 0.06% 338

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

UBS AM's MJN Position: Q2 2017 in Review

UBS AM sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 464,548 shares — an estimated $41.4M sold.

UBS AM first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $66.7M in Q4 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • UBS AM reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • UBS AM sold 464,548 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $41.4M.
  • UBS AM first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • UBS AM's Mead Johnson Nutrition Company position peaked at $66.7M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on UBS AM's 13F filing for Q2 2017, filed 11 Aug 2017.